Microbot Medical
Robotics-assisted Medical Technologies
Company Name | Updating Date | Neurotech Category | Market Category | Target Market | Technologies | Company Founded Year | Company Number of Employees |
|---|---|---|---|---|---|---|---|
Microbot Medical | 02/07/2022 | NeuroSurgery | NeuroDevices | Digital & Health care | Medical use (pharma, nerve damage rehabilitation, neurodiagnostics. inc. early diagnosis) | Robotics | 01/01/2010 | "11-50" |
Microbot Medical designs, develops, and commercializes microrobotics-assisted medical equipment designed to treat cerebrospinal fluid and gastrointestinal disorders.
The company’s ViRob is an autonomous crawling microrobot that is controlled by remotely applied electromagnetic fields and ideal for performing minimally invasive medical procedures. TipCAT is a flexible, self-propelled, semi-disposable endoscope suitable for navigating and crawling through a natural tubular lumen. Based on the ViRob technology, the Microbot SCS device is a robotic system designed to prevent occlusions in the proximal cerebrospinal fluid shunt system.
In August 2016, U.S.-based StemCells merged with Microbot Medical. In May 2018, the company announced its acquisition of a novel, patent-protected technology from CardioSert. Microbot Medical is now the owner of this technology, including all research and development information, technical know-how, and intellectual property.
Microbot Medical’s Liberty is a fully disposable robotic system for use in neurovascular, cardiovascular, and peripheral vascular procedures.